Royalty Pharma RPRX
NASDAQ RPRX
$57.63 -0.73 (-1.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Long-Term Debt Repayments (2020)

Updated

Royalty Pharma (RPRX) recorded Long-Term Debt Repayments of $1 billion in FY2025.

Analysis

Royalty Pharma (RPRX) Long-Term Debt Repayments (2020) Analysis & Trends

  • Annual Long-Term Debt Repayments has a five-year compound annual growth rate of -38.2% (FY2020 to FY2025).
  • Per Business Quant data, RPRX's Long-Term Debt Repayments was $1 billion in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Rocket Companies 43.26 Bn 28.94 Bn - -
2 Orix 42.40 Bn 42.90 Bn - -
3 Royalty Pharma 33.56 Bn 33.47 Bn - -
4 Federal National Mortgage Association Fannie Mae 24.47 Bn 24.47 Bn - 155.22 Bn
5 Affirm Holdings 23.34 Bn 17.03 Bn - 9.80 Bn
6 Synchrony Financial 23.06 Bn -44.91 Bn - -
7 Royal Gold 19.98 Bn 19.21 Bn 390.45 Mn 200.00 Mn
8 Annaly Capital Management 14.18 Bn 5.27 Bn - 2.15 Bn
9 Ares Capital 13.71 Bn 11.15 Bn - 3.11 Bn
10 Federal Home Loan Mortgage 12.39 Bn -6.35 Bn - 134.55 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 5.95 Bn
Mar 31, 2020 5.17 Bn
API Access

Royalty Pharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=RPRX&period=max&api_key=YOUR_API_KEY